reports
FedEx Corp: 1 director
A director at FedEx Corp bought 1,000 shares at 273.980USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- Jonathan Moreland
- Jonathan Moreland
Lifecore Biomedical Further Strengthens Financial Position Through Sal...
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue CHASKA, Minn., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has entered into a sales agreement with a non-competitive buyer for the company’s previously purchased, but not yet instal...
- Jonathan Moreland
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ETON ETON PHARMACEUTICALS
RLAY RELAY THERAPEUTICS
BIGZ BLACKROCK INNOVATION AND GROWTH TST
BUKS BUTLER NATIONAL CORP
GLSI GREENWICH LIFESCIENCES INC
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
MIO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
EVM EATON VANCE INSD CALIF MUN BD FD
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthca...
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 43rd Annual J.P. Morgan Healthcare Conference. The conference will take place January 13-16, 2025, in San Francisco, California. Details regarding Lifecore’s participation are as follows: 43rd Annual J.P. Morgan Healthcare ConferenceDetails: Lifecore management, includin...
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
HPP HUDSON PACIFIC PROPERTIES INC.
VVI VIAD CORP
VRSN VERISIGN INC.
OMEX ODYSSEY MARINE EXPLORATION INC.
MMS MAXIMUS INC.
KVHI KVH INDUSTRIES INC.
FPI FARMLAND PARTNERS REIT
FDX FEDEX CORPORATION
DEA EASTERLY GOVERNMENT PROPERTIES INC
CDXS CODEXIS
ASA ASA
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
CULP CULP INC.
PLSE PULSE BIOSCIENCES
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
DMLP DORCHESTER MINERALS L.P.
ZIVO ZIVO BIOSCIENCE
WHLM INC.
LOVE WILHELMINA INTERNATIONAL
FUND LOVESAC
MCFT ROYCE FOCUS TRUST
PGNY INC.
OXLC MASTERCRAFT BOAT HOLDINGS
ZYME PROGYNY
DCTH OXFORD LANE CAPITAL CORP.
REYN ZYMEWORKS INC.
PRLD DELCATH SYSTEMS
DLHC REYNOLDS CONSUMER PRODUCTS INC.
MASS PRELUDE THERAPEUTICS
NOTV DALEIGH HOLDINGS CORP
PFX 908 DEVICES
XLO INOTIV
NVCT INC.
ANEB PHENIXFIN CORP
BHVN XILIO THERAPEUTICS INC
BUKS NUVECTIS PHARMA INC
ECBK ANEBULO PHARMACEUTICALS INC
GLSI BIOHAVEN LTD
MEGI BUTLER NATIONAL CORP
SCWO ECB BANCORP INC.
SRFM GREENWICH LIFESCIENCES INC
OCX MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
SUNS 374WATER INC
SIRI SURF AIR MOBILITY INC.
TXO ONCOCYTE CORPORATION
MRKR SUNRISE REALTY TRUST
TTGT SIRIUS XM HLDGS INC NEW
KALA MORNINGSTAR PARTNERS
DTIL L.P.
MARKER THERAPEUTICS INC
TECHTARGET INC.
KALA BIO INC
PRECISION BIOSCIENCES INC.
- Jonathan Moreland
- Jonathan Moreland
CDXS CODEXIS
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
ANAB ANAPTYSBIO INC.
FUND ROYCE FOCUS TRUST
GRX INC.
ZYME THE GABELLI HEALTHCARE & WELLNESSRX TRUST
BIGZ ZYMEWORKS INC.
GLSI BLACKROCK INNOVATION AND GROWTH TST
MEGI GREENWICH LIFESCIENCES INC
TXO MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
MORNINGSTAR PARTNERS
L.P.
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Resul...
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update -- Recorded Revenues of $32.6 Million for Q2 Fiscal 2025 -- -- Signed Multiple Development Agreements with New Customers -- -- Strengthened Balance Sheet with Financing Raising Approximately $24.3 Million, and Favorable Restructuring of Credit Facility with BMO -- Conference Call Today at 4:30pm ET CHASKA, Minn., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), tod...
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
PSEC PROSPECT CAPITAL CORPORATION
OMEX ODYSSEY MARINE EXPLORATION INC.
GLP GLOBAL PARTNERS LP
FDX FEDEX CORPORATION
DEA EASTERLY GOVERNMENT PROPERTIES INC
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
AGR AVANGRID INC.
LW LAMB WESTON HOLDINGS INC.
DMLP DORCHESTER MINERALS L.P.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
LILA LIBERTY LATIN AMERICA A
LOVE LOVESAC
PGNY PROGYNY
ZYME ZYMEWORKS INC.
DCTH DELCATH SYSTEMS
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
ONEW ONEWATER MARINE
PRLD PRELUDE THERAPEUTICS
UAN CVR PARTNERS LP
NOTV INOTIV
RMBL INC.
VTYX RUMBLEON INC
QNRX VENTYX BIOSCIENCES INC
ANEB QUOIN PHARMACEUTICALS LTD
TCBX ANEBULO PHARMACEUTICALS INC
BIGZ THIRD COAST BANCSHARES INC
SKYH BLACKROCK INNOVATION AND GROWTH TST
SRFM SKY HARBOUR GROUP CORP
OCX SURF AIR MOBILITY INC.
MIO ONCOCYTE CORPORATION
SUNS PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
ASMB SUNRISE REALTY TRUST
BNTC ASSEMBLY BIOSCIENCES INC
EVM BENITEC BIOPHARMA INC
MRKR EATON VANCE INSD CALIF MUN BD FD
TTGT MARKER THERAPEUTICS INC
TECHTARGET INC.
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
OMEX ODYSSEY MARINE EXPLORATION INC.
GLP GLOBAL PARTNERS LP
FDX FEDEX CORPORATION
ADC AGREE REALTY CORPORATION
DMLP DORCHESTER MINERALS L.P.
PGNY PROGYNY
ZYME ZYMEWORKS INC.
PCB PACIFIC CITY FINANCIAL CORP
DCTH DELCATH SYSTEMS
PRLD PRELUDE THERAPEUTICS
UAN CVR PARTNERS LP
VTYX VENTYX BIOSCIENCES INC
IOBT IO BIOTECH INC
NVCT NUVECTIS PHARMA INC
ANEB ANEBULO PHARMACEUTICALS INC
SKYH SKY HARBOUR GROUP CORP
SRFM SURF AIR MOBILITY INC.
OCX ONCOCYTE CORPORATION
BNTC BENITEC BIOPHARMA INC
LAZR LUMINAR TECHNOLOGIES INC.
SPGC SPARTA SURGICAL CORP
MRKR MARKER THERAPEUTICS INC
TTGT TECHTARGET INC.
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of FedEx Corporation and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 19 December 2024 in which we reassessed the appropriateness of the ratings in the context...
Moody's Ratings says FedEx's ratings are not impacted by proposed sepa...
Moody's Ratings (Moody's) said the announcement that FedEx Corporation (FedEx) would separate FedEx Freight into a newly formed public company has no immediate impact on its ratings, including the Baa2 senior unsecured rating and stable outlook. The separation will modestly reduce FedEx's business d...
Lifecore Biomedical to Report Financial Results for Second Quarter of ...
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025 Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern CHASKA, Minn., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the second quarter of fiscal year 2025 on Thursday, January 2, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast ...
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services S...
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial Lifecore to Leverage Differentiated Capabilities and Knowledge in Fill and Finish to Support Nirsum’s NIH-Funded NRS-033 Development Program CHASKA, Minn., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organizati...
Lifecore Biomedical Amends and Extends Revolving Credit Facility with ...
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall Financial Position Builds Upon Other Recent Strategic Financial Activities, including $24.3 Million PIPE Financing Company Continues to Build Strong Foundation for Execution of Growth Strategy; Highlighted by Strengthened Leadership, Improved Financial Position, Enhanced Capabilities, and Expanded Capacity CHASKA, Minn., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Lifecore Biom...
Greenwich LifeSciences Partners with GIM in Italy
Greenwich LifeSciences Partners with GIM in Italy STAFFORD, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced its partnership with clinical sites in Italy. The Company has partnered with "Gruppo Italiano Mammella" (GIM), the largest academic cooperative breast cancer research group in Italy, including over 150 participating centers and approx...
Lifecore Biomedical Hosts Virtual Investor Day
Lifecore Biomedical Hosts Virtual Investor Day CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it hosted a virtual investor day prior to market open during which Lifecore’s senior management team discussed the company’s business and strategy for growth in the future, among other topics. A replay of the event is available via webcast and can be accessed by visiting the Events & Presentations section of Lifecore’s investor web page at: . ...
- Dave Nicoski
- Ross LaDuke
RRC RANGE RESOURCES CORPORATION
NWL NEWELL BRANDS INC
LNDC LANDEC CORP.
J7Z JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
EOG EOG RESOURCES INC.
DAR DARLING INGREDIENTS INC.
COG CABOT OIL & GAS CORPORATION
AR ANTERO RESOURCES CORPORATION
AMP AMERIPRISE FINANCIAL INC.
PEN PENUMBRA INC.
GDEN GOLDEN ENTERTAINMENT
TAP MOLSON COORS BEVERAGE COMPANY CLASS B
MBI MBIA INC.
SMPL SIMPLY GOOD FOODS CO
MCFT MASTERCRAFT BOAT HOLDINGS
NVST ENVISTA HOLDINGS
OVV OVINTIV INC
PL PLANET LABS PBC
ADTN ADTRAN HOLDINGS INC
DKNG DRAFTKINGS INC.
DEC DIVERSIFIED ENERGY COMPANY PLC
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.